ABL has been awarded a global client relationship agreement (GCRA), an Australian frame agreement and an international frame ...

Abacus Life, Inc. (ABL) closed the last trading session at $6.23, gaining 17.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Abacus Life ( ($ABL) ) just unveiled an update. On November 25, 2025, Abacus Global Management announced the timing of its inaugural annual cash ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

Allied Bank promotes its warehouse facility, allowing farmers and traders to use stock as collateral for financing, improving ...

The KOSPI closed higher for the third consecutive trading day. The upward momentum from the U.S. stock market carried over, ...

Air France has received its 15th and final Airbus A220-300 from ABL Aviation as part of a sale-and-leaseback agreement signed ...

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple ...

Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific antibodies. ABL Bio will receive an upfront payment and potential milestone ...

Upstream ABL, a Belfast-based structured asset based lending (ABL) specialist, has partnered with renewable energy project developer Strategic Power Group (SPG) to help create some of ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

Eli Lilly partners with ABL Biotech on bispecific antibodies via the Grabody platform in a deal worth up to $2.6B. Read more ...